Literature DB >> 1259391

Protective effect of cephalothin against gentamincin-induced nephrotoxicity in rats.

P Dellinger, T Murphy, V Pinn, M Barza, L Weinstein.   

Abstract

The possibility that the nephrotoxicity of gentamicin may be potentiated by the concomitant administration of cephalothin was examined in a rat model. Cephalothin given once daily in dosages up to 800 mg/kg per day for 10 days produced no renal damage. Gentamicin, at 6 to 50 mg/kg per day, caused pathological changes which were dosage related and affected primarily the proximal tubular cells. Administration of the two drugs simultaneously resulted in a significant protective effect of cephalothin against gentamicin-related nephrotoxicity (P < 0.01). When the daily injections of the two agents were separated by an interval of 6 h, the protective effect was lost, and the resultant damage was the same as that due to gentamicin alone. The protective effect of cephalothin was reproduced by the administration of equiosmolar amounts of sulfate (sodium sulfate), suggesting that the phenomenon might be related to the presence of nonresorbable anion in the urine. These studies indicate that, in the rat, cephalothin does not potentiate, but, in fact, may prevent the nephrotoxic effects of gentamicin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1259391      PMCID: PMC429495          DOI: 10.1128/AAC.9.1.172

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Relationship between the transport and toxicity of cephalosporins in the kidney.

Authors:  B M Tune
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

2.  Nephrotoxicity of combined cephalothin-gentamicin regimen.

Authors:  F Cabanillas; R C Burgos; C Rodríguez; C Baldizón
Journal:  Arch Intern Med       Date:  1975-06

3.  Reversible nephrotoxicity associated with cephalothin therapy.

Authors:  D P Pasternak; B G Stephens
Journal:  Arch Intern Med       Date:  1975-04

4.  Nephrotoxicity associated with cephalothin administration.

Authors:  P C Carling; B A Idelson; A A Casano; E A Alexander; W R McCabe
Journal:  Arch Intern Med       Date:  1975-06

5.  Acute renal failure during cephalothin therapy.

Authors:  J R Burton; N S Lichtenstein; R B Colvin; N E Hyslop
Journal:  JAMA       Date:  1974-08-05       Impact factor: 56.272

6.  Renal parenchymal accumulation of aminoglycoside antibiotics in rats.

Authors:  F C Luft; S A Kleit
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

7.  Acute renal failure after high doses of gentamicin and cephalothin.

Authors:  D Kleinknecht; D Ganeval; D Droz
Journal:  Lancet       Date:  1973-05-19       Impact factor: 79.321

8.  Nephrotoxicity of aminoglycosides and gentamicin.

Authors:  F G Falco; H M Smith; G M Arcieri
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

9.  Predictability of blood levels of gentamicin in man.

Authors:  M Barza; R B Brown; D Shen; M Gibaldi; L Weinstein
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

10.  Gentamicin nephrotoxicity: failure of three cephalosporins to potentiate injury in rats.

Authors:  W O Harrison; F J Silverblatt; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

View more
  11 in total

1.  Effect of cephalothin on renal cortical concentrations of gentamicin in rats.

Authors:  P Dellinger; T Murphy; M Barza; V Pinn; L Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

2.  Nephrotoxicity of cephalosporin-gentamicin combinations in rats.

Authors:  F C Luft; V Patel; M N Yum; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1976-05       Impact factor: 5.191

3.  Protection from gentamicin nephrotoxicity by cephalothin and carbenicillin.

Authors:  R Bloch; F C Luft; L I Rankin; R S Sloan; M N Yum; D R Maxwell
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

4.  Effect of timing of cefuroxime dosage on its protection of rats against gentamicin nephrotoxicity.

Authors:  K Capel-Edwards; R M Atkinson; J M Wheeldon; D A Pratt; G G Patterson; I W Harman; R D Foord
Journal:  Infection       Date:  1980       Impact factor: 3.553

5.  Effect of cefamandole nafate on the toxicity of tobramycin.

Authors:  J S Wold; S A Turnipseed; W D Broddle; N V Owen
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

6.  Comparative nephrotoxicities of netilmicin and gentamicin in rats.

Authors:  F C Luft; M N Yum; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

7.  Ceftriaxone protects against tobramycin nephrotoxicity.

Authors:  D Beauchamp; G Thériault; L Grenier; P Gourde; S Perron; Y Bergeron; L Fontaine; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

8.  Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.

Authors:  J Kuhlmann; G Seidel; H Grötsch
Journal:  Infection       Date:  1982       Impact factor: 3.553

9.  Protective effect of piperacillin against nephrotoxicity of cephaloridine and gentamicin in animals.

Authors:  T Hayashi; Y Watanabe; K Kumano; R Kitayama; T Yasuda; I Saikawa; J Katahira; T Kumada; K Shimizu
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

10.  Effects of various cephalosporins on the proximal tubule of the human kidney.

Authors:  A W Mondorf; M Zegelman; J Klose; L Maske; J E Scherberich; T Stefanescu; H Müller; W Schoeppe
Journal:  Eur J Clin Pharmacol       Date:  1978-07-30       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.